Skip to main content
    C

    Cronos Group Inc (CRON)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ

    $3.61
    -0.11 (-2.96%)

    Market Cap: $1.37B

    Last updated: Nov 06, 2026 at 4:21 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    50%(19/38)
    Avg Surprise
    +65.09%
    Streak
    3 Q

    Upcoming Estimates

    Period ending Dec 31, 2026
    EPS Consensus$0.17
    Range$0.12 - $0.23
    5 analysts
    Revenue Consensus
    $110M
    Range$102M - $116M
    5 analysts
    Last 12 of 39 reported quarters and 1 upcoming estimate
    PeriodReportedEst.RangeSurpriseB/MAnalystsRevisionsYoY
    Dec 26EST
    		-$0.17$0.12 - $0.23--5--
    Sep 26
    Reported Nov 5
    		$0.04$0.03$0.03 - $0.07+33.33%Beat3
    0
    1
    30d
    		-60.0%
    Jun 26
    Reported Aug 6
    		$0.03$0.01$0.01 - $0.01+200.00%Beat2
    0
    1
    30d
    		+130.0%
    Mar 26
    Reported May 11
    		$0.05$0.01$0.00 - $0.01+400.00%Beat2
    0
    1
    30d
    		+66.7%
    Dec 25
    Reported Feb 26
    		$-0.00N/A--147.00%Miss3
    No revisions (30d)
    		-103.0%
    Sep 25
    Reported Nov 6
    		$0.10$0.02$0.02 - $0.02+400.00%Beat1
    No revisions (30d)
    		+233.3%
    Jun 25
    Reported Aug 7
    		$-0.10$-0.02$-0.02 - $-0.02-400.00%Miss0
    No revisions (30d)
    		-400.0%
    Mar 25
    Reported May 8
    		$0.03$-0.00$-0.00 - $-0.00+957.14%Beat0
    No revisions (30d)
    		+400.0%
    Dec 24
    Reported Feb 27
    		$0.16$-0.01$-0.01 - $-0.01+1806.45%Beat0
    No revisions (30d)
    		+417.4%
    Sep 24
    Reported Nov 12
    		$0.03$-0.01$-0.02 - $0.00+400.00%Beat3
    No revisions (30d)
    		+250.0%
    Jun 24
    Reported Aug 8
    		$-0.02N/A-+71.43%Beat4
    No revisions (30d)
    		+33.3%
    Mar 24
    Reported May 9
    		$-0.01$-0.01$-0.02 - $-0.01+0.00%Beat3
    No revisions (30d)
    		+66.7%
    Dec 23
    Reported Feb 29
    		$-0.05$-0.01$-0.02 - $-0.01-400.00%Miss2
    No revisions (30d)
    		+76.2%

    Key Metrics

    Valuation
    P/E Ratio31.31EV/EBITDA23.26x
    Price/FCF20.24xFCF Yield4.94%
    Profitability
    Profit Margin39.10%Operating Margin15.40%
    ROE7.05%ROICN/A
    Financial Health
    Debt/Equity0.00xInterest CoverageN/A
    Current Ratio12.71xQuick Ratio11.91x
    Trading Statistics
    Beta1.25Avg Volume1.06M
    52-Week High$3.9152-Week Low$2.28

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$3.42
    SMA 20$3.35
    SMA 50$3.31
    SMA 200$2.88
    EMA 10$3.46
    EMA 20$3.39
    EMA 50$3.29
    EMA 200$2.95

    MACD

    Line: 0.07Signal: 0.04Hist: 0.03

    ADX

    ADX: 22.3+DI: 37.9-DI: 12.0

    Aroon & PSAR

    Aroon Up96.0
    Aroon Down16.0
    PSAR$3.37

    Bollinger Bands

    Upper Band$3.63
    Lower Band$3.06
    %B Position1695%(Upper)
    Band Width0.96

    RSI (14-Day)

    Neutral
    64.2

    Momentum Oscillators

    Stoch %K70.5
    Stoch %D72.4
    Williams %R-45.5
    ROC (10d)7.8%
    Momentum0.26
    CCI (20d)187.7
    MFI (14d)74.0

    Volatility Measures

    ATR (14d)$0.13(3.5%)
    StdDev (20d)0.14
    Hist Vol35.2%(Moderate)

    Volume Flow

    VWAP$3.62
    OBV84.7M
    AD Line-62.5M
    CMF (20d)-0.156

    Volume Metrics

    Avg Vol (20d)1.1M
    Vol Ratio1.2x
    VWMA (20d)$3.42

    Pivot Points

    R3$4.20
    R2$4.05
    R1$3.89
    Pivot Point$3.74
    S1$3.58
    S2$3.43
    S3$3.27

    Advanced Oscillators

    TSI20.46
    Ultimate Osc48.1
    KST46.32

    Financial Data

    QuarterSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total Revenue$83.90M$53.01M$45.21M$32.04M$48.83M$33.45M$32.26M$30.30M$34.26M$27.76M$25.29M$23.91M
    Cost of Revenue$51.62M$24.56M$26.06M$15.85M$30.50M$18.95M$18.53M$19.49M$30.65M$21.46M$20.80M$22.00M
    Gross Profit$32.28M$28.45M$19.15M$16.19M$18.33M$14.50M$13.73M$10.81M$3.61M$6.30M$4.48M$1.91M
    Operating Expenses$23.26M$21.05M$20.99M$23.68M$18.84M$19.83M$17.81M$22.17M$37.27M$21.86M$20.43M$23.55M
    R&D$1.34M$1.22M$1.41M$1.38M$1.34M$929,000$793,000$1.03M$1.24M$962,000$997,000$1.45M
    SG&A$12.00M$10.80M$11.74M$12.90M$9.25M$10.54M$9.31M$12.08M$12.76M$12.77M$8.91M$9.80M
    Operating Income$9.03M$7.40M$-1,833,000$-7,496,000$-503,000$-5,324,000$-4,072,000$-11,365,000$-33,655,000$-15,561,000$-15,948,000$-21,636,000
    Interest Income$9.24M$8.82M$8.85M$9.56M$11.74M$9.00M$9.66M$-20,606,000$44.93M$14.37M$15.69M$14.97M
    Interest Expense$0$0$0$4.89M$0$33.68M$0$0$0$0$0$23.88M
    Income Before Tax$18.72M$35.71M$18.14M$-12,386,000$27.00M$-39,007,000$7.27M$45.95M$4.62M$-10,933,000$-3,042,000$-45,511,000
    Income Tax Expense$898,000$51,000$2.43M$-11,895,000$-1,316,000$-525,000$-455,000$2.00M$-2,708,000$-2,174,000$-558,000$-360,000
    Net Income$17.83M$35.66M$15.71M$-491,000$28.32M$-38,482,000$7.72M$43.94M$7.32M$-8,759,000$-2,484,000$-45,027,000
    EBITDA$14.19M$30.27M$13.01M$-18,288,000$18.80M$-43,802,000$443,000$69.08M$-36,746,000$-23,788,000$-17,004,000$-59,300,000
    EBIT$9.48M$26.90M$9.29M$-21,945,000$15.26M$-48,004,000$-2,397,000$66.55M$-40,313,000$-25,301,000$-18,735,000$-60,477,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about CRON

    News

    Cronos Group (NASDAQ:CRON) Posts Earnings Results, Beats Estimates By $0.01 EPS

    Cronos Group (NASDAQ:CRON) reported strong Q3 earnings, beating analyst estimates by $0.01 EPS with $0.04 earnings per share. The company achieved record net revenue of $63.5 million, a 75% year-over-year increase...

    MarketBeat•11/5/26•Bullish

    Strong International Demand Drives Cronos Group Q3 Results

    Cronos Group Inc. reported a significant 75% year-over-year increase in net revenue to US$63.5 million for Q3 2026, driven primarily by strong cannabis flower sales in Israel, Germany...

    StratCann•11/5/26•Bullish

    Cronos Group stock hits 52-week high at 3.71 USD

    Cronos Group Inc. (CRON) stock recently reached a 52-week high of $3.61, representing a 43% increase over the past year and bringing its market capitalization to $1.3 billion. Despite trading above its InvestingPro Fair...

    Investing.com•11/5/26•Bullish

    Cronos Group Shares Rise After Q3 Beat and 75% Revenue Growth

    Cronos Group Inc. shares rose in premarket trading after the Canadian cannabis producer announced third-quarter 2026 results that surpassed expectations. The company reported a 75% year-over-year revenue increase...

    www.tokenpost.com•11/5/26•Bullish

    Q3 revenue rises to $63.5M at Cronos Group (CRON), but net income falls.

    Cronos Group (CRON) reported a significant increase in Q3 2026 net revenue to $63.5 million, up from $36.3 million in the prior year, primarily driven by higher cannabis sales in Israel, Germany...

    Stock Titan•11/5/26•Somewhat-Bullish

    CRON Valuation and Fair Value

    P/E
    31.3x
    Forward P/E
    20.9x
    EV/EBITDA
    23.3x
    P/FCF
    20.2x
    P/B
    1.2x
    See GNG's fair value

    CRON Profitability: Margins, ROIC and FCF

    Gross margin
    44.9%
    Operating margin
    15.4%
    Net margin
    39.1%
    ROE
    7.0%
    FCF margin
    30.5%
    FCF yield
    4.9%

    CRON Competitors

    CompanyTicker
    Innoviva IncINVA
    Kalvista Pharmaceuticals IncKALV
    Pennant Group IncPNTG
    Structure Therapeutics Inc. American Depositary SharesGPCR
    Nutex Health IncNUTX
    Eton Pharmaceuticals IncETON
    Rapport Therapeutics, Inc. Common StockRAPP
    Mineralys Therapeutics, Inc. Common StockMLYS

    Sector: Healthcare

    CRON Analyst Ratings

    Consensus
    Buy
    Analysts
    4
    Strong Buy
    0
    Buy
    3
    Hold
    1
    Sell
    0
    Strong Sell
    0

    CRON Bull Case vs Bear Case

    Bull case

    • CRON converts 30.5% of revenue into free cash flow.
    • CRON has a 39.1% net profit margin.
    • CRON beat EPS estimates in 75.0% of its last 8 reported quarters.

    CRON Earnings: Beat Rate and Next Report

    Beat rate
    6 of 8 quarters (75.0%)
    Average surprise
    406.2%
    EPS estimate (fiscal period ending Dec 31, 2026)
    $0.17

    CRON Earnings Call

    The latest CRON earnings call transcript on file is labeled 2026Q2.

    Read the 2026Q2 transcript

    CRON ETF Holders

    GNG tracks 1 ETF that holds CRON.

    1. Dimensional International Core Equity Market ETF (DFAI), <0.01% of the fund
    Open the ETF Stock Exposure tool for CRON

    See insider activity

    Frequently Asked Questions About CRON

    Does CRON pay dividends?

    Cronos Group Inc (CRON) does not currently pay a regular dividend.

    What is CRON's P/E ratio?

    Cronos Group Inc has a price-to-earnings (P/E) ratio of 31.31.

    What is CRON's market cap?

    Cronos Group Inc (CRON) has a market capitalization of $1.37B with a current stock price of $3.61.

    Related stocks

    Sector: Healthcare

    All stocks starting with C

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In